DES and neoplasm: In contrast, multivariate analysis of VI evaluated by dual CD31‒desmin immunolabeling showed that poor tumor differentiation (P < 0.001), perineural invasion (P = 0.019), and VI detected by dual immunolabeling (P = 0.009) were independent prognostic factors of worse disease-free survival.